• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Ophthalmol . Prevalence, patterns, and predictors of SARS-CoV-2 RNA and culturable virus in tears of case-ascertained household cohort

tetano

Editor, Senior Moderator
Am J Ophthalmol


. 2024 Apr 23:S0002-9394(24)00149-1.
doi: 10.1016/j.ajo.2024.04.008. Online ahead of print. Prevalence, patterns, and predictors of SARS-CoV-2 RNA and culturable virus in tears of case-ascertained household cohort

Matthew So[SUP] 1 [/SUP], Sarah A Goldberg[SUP] 2 [/SUP], Scott Lu[SUP] 2 [/SUP], Miguel Garcia-Knight[SUP] 3 [/SUP], Michelle C Davidson[SUP] 4 [/SUP], Michel Tassetto[SUP] 3 [/SUP], Victoria Wong Murray[SUP] 5 [/SUP], Khamal Anglin[SUP] 6 [/SUP], Jesus Pineda-Ramirez[SUP] 6 [/SUP], Jessica Y Chen[SUP] 6 [/SUP], Paulina R Rugart[SUP] 7 [/SUP], Eugene T Richardson[SUP] 8 [/SUP], Melissa Briggs Hagen[SUP] 9 [/SUP], Claire M Midgley[SUP] 9 [/SUP], Raul Andino[SUP] 3 [/SUP], Gerami D Seitzman[SUP] 10 [/SUP], John Gonzales[SUP] 10 [/SUP], Michael J Peluso[SUP] 11 [/SUP], Jeffrey N Martin[SUP] 7 [/SUP], J Daniel Kelly[SUP] 12 [/SUP]



Affiliations
Abstract

Purpose: To investigate the prevalence, patterns, and predictors of SARS-CoV-2 RNA and culturable virus in tears of case-ascertained household cohort.
Design: Prospective, longitudinal case-ascertained household cohort identified through convenience sampling.
Methods: This analysis was restricted to individuals who were non-hospitalized, symptomatic, and tested positive for SARS-CoV-2 by nasal RT-PCR. Tears and anterior nasal biospecimens were serially collected throughout the acute period. Tears specimens were collected by the study staff using Schirmer test strips, and nasal specimens were self-collected. For both, SARS-CoV-2 RNA was quantified using qRT-PCR and culturable virus was detected using presence of cytopathic effect (CPE) in tissue culture; positive CPE was confirmed by a qRT-PCR step. A series of cross-sectional unadjusted analyses were performed investigating the relationship between different sociodemographic determinants and biological factors associated with tears RNA positivity.
Results: Among the 83 SARS-CoV-2 infected participants, ten (12%) had at least one RNA positive tears specimen. Amongst these ten, five (50%) had concurrent presence of culturable virus, at a median of 7 days post symptom onset (IQR: 4-7 days) (absolute range: 4-8 days).
Conclusions: In this longitudinal cohort, we found evidence of culturable virus in the tears of a small proportion of non-hospitalized SARS-CoV-2 infected individuals. Current public health infection precautions do not account for transmission via tears, so these findings may improve our understanding of potential sources of SARS-CoV-2 transmission and contribute to developing future guidelines.

Keywords: COVID-19; Culturable; Non-hospitalized; RNA Detection; SARS-CoV-2; Tears.

 
Back
Top Bottom